Pharmaceutical Cartridges Market by Material, Capacity, and Geography - Forecast and Analysis 2023-2027

Pharmaceutical Cartridges Market Forecast 2023-2027

The global pharmaceutical cartridges market is estimated to grow by USD 540.18 million at a Compound annual growth rate (CAGR) of 6.32% between 2022 and 2027. 

The market expansion hinges on various factors, including heightened R&D investments within the pharmaceutical sector, driving innovation and the development of Novel active substances (NAS) and novel drugs. Additionally, the global surge in pharmaceutical sales underscores increasing demand and consumption, further stimulating market growth. Moreover, the rising preference for convenience prompts a surge in demand for streamlined and user-friendly pharmaceutical packaging solutions. As pharmaceutical companies strive to meet evolving consumer needs and regulatory standards, the market for pharmaceutical packaging is poised for substantial growth, propelled by ongoing advancements and a focus on enhancing patient experience and product accessibility.

What will be the size of the Market During the Forecast Period?

To learn more about this report, Download Report Sample

Market Dynamics and Customer Landscape

The market encompasses the production, procurement, and distribution of cartridges used in pharmaceutical applications. These cartridges are essential components in various medical devices, such as insulin pens and infusion pumps, used for delivering drugs and vaccines. The market is driven by the increasing prevalence of chronic conditions (diabetes & arthritis), rising demand for home healthcare, and technological advancements in medical devices. Additionally, the market is segmented based on material type, application, and region. Major players in the market include INsulet Corporation, InnovaCare, Plastics Injection Molding, Newell Brands, and Nipro Corporation. These companies focus on innovation, product development, and strategic collaborations to cater to the growing demand. One of the key challenges in healthcare settings is needle sticks, which can result in accidental exposure to bloodborne pathogens. Pharmaceutical cartridges address this concern by providing a secure and reliable delivery mechanism, reducing the likelihood of needle stick injuries. The increase in R&D spending in the pharmaceutical industry is notably driving the market growth, although factors such as increasing use of alternatives may impede the market growth. Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.

Key Driver

The increase in R&D spending in the pharmaceutical industry is the key factor driving market growth. Many pharmaceutical companies are investing heavily in R&D. The market is experiencing significant growth due to the substantial investment in Research and Development (R&D) by pharmaceutical manufacturers. On average, these companies allocate 15% to 20% of their revenue towards R&D. For instance, Biogen and F. Hoffmann-La Roche spent approximately 18% to 20% of their revenue on R&D in 2020. This increased spending is anticipated to result in an expansion of pharmaceutical products, particularly in the areas of malignancies, parenteral drugs, and specialty drugs. Manufacturing processes for pharmaceutical cartridges involve the use of materials such as plastic. Plastic cartridges, made from plastic material, are increasingly popular due to their precision in dose delivery and patient safety. Medical professionals rely on these cartridges for the administration of oral medicine and parenteral medications, including subcutaneous administration. Regulatory bodies closely monitor the manufacturing processes and proper packaging of pharmaceutical cartridges to ensure patient safety and compliance. Technological advancements have led to the development of smart packaging features, needle free pen injectors, and wearable injectors.

These innovations cater to the demand for safe storage, patient compliance, and precise dose delivery. Pharmaceutical cartridges are essential for the administration of various medications, including vaccines and treatments for rare diseases like renal disease and renal failure. The market for parenteral packing is expected to grow due to the increasing need for vaccine manufacturing capabilities and the development of new medication delivery technologies, such as prefilled syringes and thermal shock-resistant cartridges. the market is driven by the R&D investment of pharmaceutical manufacturers, the need for precise dose delivery, and the development of innovative technologies to ensure patient safety, compliance, and quality. Regulatory monitoring plays a crucial role in maintaining the market's integrity while the demand for cartridges in the administration of various medications, including parenteral drugs and vaccines, continues to grow. The rising R&D spending by pharmaceutical manufacturers is expected to boost the growth of the market during the forecast period.

Significant Trend

The increase in patent expiration is one of the major market trends. The number of patent expirations in the pharmaceutical industry is expected to increase at an average year-over-year growth of 3% during the forecast period. The market is experiencing significant growth due to the increasing expiration of patents for parenteral medications and specialty drugs, leading to an increase in demand for affordable alternatives. This trend is particularly noticeable in the treatment of malignancies and renal disease. Manufacturing processes for cartridges involve the use of materials such as plastic and glass. Phillips Medisize and other vendors in the market offer expertise and infrastructure for glass packaging, which is essential for patient safety and compliance, especially for needle free pen injectors and prefilled syringes. New products, such as smart packaging features and wearable injectors, are driving technological advancements in the market. Regulatory bodies closely monitor the manufacturing processes and quality standards to ensure patient safety and proper packaging, including protection against thermal shock and thermal stress during storage and transportation.

Vaccine manufacturing capabilities are also a significant factor in the growth of the pharmaceutical cartridges market, as vaccines require precise dosing and safe storage. This, in turn, fuels the growth of pharmaceutical cartridges, as Companies in the market in focus have the required infrastructure and skilled expertise to provide glass packaging services. Thus, the increasing number of patent expiration will drive the growth of the market during the forecast period.

Major Challenge

Increasing the use of alternatives is a major challenge in market growth. Prefilled syringes have emerged as one of the fastest-growing methods of administering unit-dose medication as the pharmaceutical industry seeks new and more convenient drug delivery methods. The market is subject to stringent regulations due to the sensitive nature of the materials involved. In the US, the Federal Food, Drugs, and Cosmetic Act of 1938 and the Fair Packaging and Labelling Act of 1967 set the standards for pharmaceutical packaging. Similarly, in APAC, regulatory bodies like the China Food and Drug Administration (CFDA) oversee food and beverage packaging hygiene permits. Manufacturing processes, including plastic material for parenteral drugs and prefilled syringes, must meet rigorous quality standards. Materials used for oral medicine administration and subcutaneous injection, such as plastic cartridges and pen injectors, require approvals to ensure patient safety and compliance.

Regulatory monitoring is crucial for medical professionals and patients, as proper packaging is essential for maintaining the precise dose, preventing needles sticks, and ensuring safe storage. Technological advancements, like smart packaging features and wearable injectors, enhance patient safety and improve patient compliance for specialty drugs, malignancies, renal disease, and renal failure. Phillips Medisize and other vendors catering to the pharmaceutical packaging industry must adhere to regulatory bodies' guidelines to eliminate adulteration risks. Vaccine manufacturing capabilities also require thermal shock and thermal stress resistance to maintain the efficacy of vaccines. New products, such as needle free injection systems and advanced parenteral packing demand, undergo thorough regulatory monitoring to ensure safety and quality.Simple and flexible processing formats make them easier to use and beneficial, especially for patients who need to self-inject medication but have no medical training. Hence, prefilled syringes are gaining popularity, which will be a key challenge for the market during the forecast period.

Customer Landscape

The market research and growth report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the market growth and forecasting report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.

Customer Landscape

Who are the Major Market Companies?

Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.

Britomatics - The company offers pharmaceutical cartridges such as Meltblown Filter Cartridges.

The market growth analysis report also includes detailed analyses of the competitive landscape of the market and information about 15 market Companies, including:

• Ambica Pharma Machines Pvt. Ltd.
• AptarGroup Inc.
• Baxter International Inc.
• Camfil AB
• Datwyler Holding Inc.
• Gerresheimer AG
• groninger and co. gmbh
• Hubena
• Kalbag Filters Pvt. Ltd.
• KEL India FILTERS
• Maquinaria Industrial Dara SL
• Merck KGaA
• Nipro Corp.
• SCHOTT AG
• SGD S.A.

Qualitative and quantitative analysis of Companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize Companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize Companies as dominant, leading, strong, tentative, and weak.

Market Segmentation

The market is a significant segment in the healthcare industry, utilizing advanced technologies to deliver precise dosages of medications. These cartridges, which include 3ml, MTL, and LCG cartridges, are essential components in various medical devices such as insulin pumps, inhalers, and automatic injectors. Manufacturers like Advanced, Canter, and Doseme produce these cartridges using materials like glass and plastic, ensuring durability and compatibility with different medical devices. The market is driven by factors such as the increasing prevalence of chronic diseases, rising demand for self-administered therapies, and technological advancements in medical devices. Moreover, regulatory bodies like the FDA play a crucial role in ensuring the safety and efficacy of these cartridges. The market is expected to grow at a steady pace due to the increasing adoption of self-administered therapies and the development of advanced medical devices. The market is a vital sector in the healthcare industry, providing essential components for various medical devices and contributing to the advancement of self-administered therapies.

By Material

The market share growth by the glass segment will be significant during the forecast period. Glass was the largest segment of the market in 2022 and will continue to remain the largest segment during the forecast period primarily due to its barrier properties that prevent oxygen and water vapor from interacting with drug compounds. Glass is the most prominently used material for the manufacturing of pharmaceutical cartridges. 

Get a glance at the market contribution of various segments Request a PDF Sample

The glass segment was valued at USD 860.71 million in 2017 and continue to grow by 2021. Glass cartridges are compatible with different filling machines, which makes it easy for pharmaceutical companies to integrate glass into their operations. The market is primarily driven by the use of glass as a material due to its barrier properties that ensure patient safety and medication stability against oxygen and water vapor. Glass cartridges, particularly type 1 borosilicate, dominate the market for manufacturing parenteral medications, including specialty drugs and vaccines. In contrast, plastic cartridges are also used due to their stability, inert properties, and regulatory ease. Manufacturing processes for pharmaceutical cartridges involve careful consideration of patient safety, quality, and regulatory monitoring. Materials like glass and plastic are chosen based on their compatibility with different filling machines and their ability to ensure precise doses. Medical professionals rely on cartridges for oral medicine administration and subcutaneous injection of parenteral medications.

Patient compliance and safety are crucial factors, with cartridges offering features like smart packaging and wearable injectors. Technological advancements, such as pen injectors and Phillips Medisize's innovative designs, contribute to the market's growth. Regulatory bodies closely monitor the industry to ensure proper packaging, safe storage, and thermal shock resistance. Cartridges are essential for administering medications for various conditions, including malignancies, renal disease, and renal failure. New products and vaccine manufacturing capabilities continue to expand the market's potential.. The rising use and demand for antibody drugs are expected to increase the need for glass cartridges. Therefore, the global pharmaceutical cartridge market is expected to grow during the forecast period.

Regional Analysis

North America is estimated to contribute 37% to the growth of the global market during the forecast period. The North American market for pharmaceutical cartridges, including 3ml and dual chamber variants, leads the global industry. Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.

For more insights on the market share of various regions Request PDF Sample now!

Factors fueling growth include advanced materials for anti-contamination, compliance with regulations like the Drug Supply Chain Security Act, and customer preference for convenience and dose accuracy. Key applications include diabetes management, cancer treatment, and biologics for chronic diseases such as arthritis, cardiovascular illnesses, hepatic failure, and chronic intestinal and respiratory conditions. Innovations like nanotechnology and injection machines cater to the need for dose accuracy and convenience. Glass cartridges are widely used for liquid pharmaceuticals, including insulin, due to their dimensional tolerances and resistance to leaching. Healthcare infrastructure development and the increasing prevalence of chronic disorders drive demand. However, potential accidents and damage during long-term storage remain challenges.

Market Analyst Overview

The market is witnessing significant growth, primarily driven by the increasing demand for drug delivery devices to manage chronic conditions such as diabetes and arthritis. Insulin delivery, in particular, has seen a surge in demand, leading companies like SCHOTT Pharma and Thermo Fisher Scientific, Inc. to focus on ready to use cartridge production brands like Ompi. Additionally, advancements in technology have led to the development of innovative products like plastic cartridges, pen injectors, and wearable injectors by companies like Phillips-Medisize and Tandem Diabetes Care, Inc. Furthermore, the introduction of dual chamber cartridges and devices like the Sigi Patch Pump by AMF Medical SA are revolutionizing diabetes management. This segment within the pharmaceutical industry continues to expand rapidly, catering to the evolving needs of patients worldwide.

The market is witnessing significant growth, driven by various factors such as increasing demand for long-term storage solutions and the adoption of new medication delivery technologies by biotech and biopharma firms. Patient safety remains a key focus, with advancements in dose accuracy and convenience driving innovation in drug delivery devices like pen injectors and dual chamber cartridges. Compliance with stringent regulatory standards, particularly regarding anti-contamination and labeling, is crucial to ensure the integrity and efficacy of parenteral medications. Additionally, advancements in materials such as glass and plastic are enhancing dimensional tolerances and reducing the risk of leaching, further bolstering the market's expansion.

Segment Overview

The market research report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2017 to 2027. 

• Material Outlook
  • Glass
  • Plastic

• Capacity Outlook
  • Below 5 ml
  • 5-50 ml
  • 51-250 ml
  • Above 250 ml

• Region Outlook
  • North America
    • The U.S.
    • Canada
  • Europe
    • The U.K.
    • Germany
    • France
    • Rest of Europe
  • Asia
    • China
    • India
  • Rest of World (ROW)
    • Chile
    • Argentina
    • Brazil
    • Rest of the Middle East & Africa

 

Market Scope
Report Coverage	Details
Page number	168
Base year	2022
Historic period	2017 - 2021
Forecast period	2023-2027
Growth momentum & CAGR	Accelerate at a CAGR of 6.32%
Market growth 2023-2027	USD 540.18 million
Market structure	USD Fragmented
YoY growth 2022-2023(%)	5.5
Regional analysis	North America, Europe, Asia, and Rest of World (ROW)
Performing market contribution	North America at 37%
Key countries	US, Canada, Germany, UK, and China
Competitive landscape	Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks
Key companies profiled	Ambica Pharma Machines Pvt. Ltd., AptarGroup Inc., Baxter International Inc., Britomatics Engineers Pvt. Ltd., Camfil AB, Datwyler Holding Inc., Gerresheimer AG, groninger and co. gmbh, Hubena, Kalbag Filters Pvt. Ltd., KEL India FILTERS, Maquinaria Industrial Dara SL, Merck KGaA, Nipro Corp., SCHOTT AG, SGD S.A., Shandong Pharmaceutical Glass Co. Ltd., Stevanato Group S.p.A, Transcoject GmbH, and West Pharmaceutical Services Inc.
Market dynamics	Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, Market growth and Forecasting, COVID 19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period
Customization purview	If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Request PDF sample

What are the key data covered in this Market Report?

• CAGR of the market during the forecast period
• Detailed information on factors that will drive the growth of the market between 2023 and 2027
• Precise estimation of the size of the market size and its contribution to the parent market
• Accurate predictions about upcoming trends and changes in consumer behavior
• Growth of the market industry across North America, Europe, Asia, and Rest of World (ROW)
• Thorough analysis of the market’s competitive landscape and detailed information about Companies
• Comprehensive analysis of factors that will challenge the growth of market Companies

We can help! Our analysts can customize this report to meet your requirements. Get in touch